Accurate diagnosis·decoding of life code, defining a healthy future

At RoJure Medicine, we firmly believe that "precision" is one of the core values of modern medicine. Relying on advanced molecular biology platforms and artificial intelligence algorithms, the RoJure precision diagnostic system provides strong scientific support for early disease screening, personalized treatment plan development, and prognosis management through in-depth analysis of multiple omics data such as genes, proteins, and metabolomics.

We have established a diagnostic model system covering multi omics integrated analysis, intelligent risk modeling, and dynamic health profiling construction around core areas such as cancer, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, and genetic diseases, achieving a qualitative change from "detection" to "insight".

Core competencies include:

• High throughput gene testing: covering multiple detection pathways such as whole exome, specific targeted panels, tumor tissue and liquid biopsy (ctDNA), etc;

• AI driven risk prediction: combining big data and deep learning to construct a highly sensitive disease risk scoring model;

• Accurate classification and medication guidance: achieve disease subtype identification and drug response prediction, and assist in individualized clinical decision-making;

• Data security and compliance assurance: All data processing procedures strictly follow international ISO and CNAS standards to ensure user privacy and data compliance.

RoJure precision diagnosis is not only about testing, but also a comprehensive intelligent solution that covers the entire process from genes to disease risk, from results to health decision-making. We are committed to transforming complex life information into clinical value, allowing everyone to have control over their own health sovereignty.